oral semaglutide launch Novo Nordisk to Ozempic for type 2 diabetes in US Novo Nordisk's weight-loss pill wins

GLP-1s and Metabolic Health Metabolic dysfunction, which includes conditions like obesity, type 2 diabetes, and metabolic syndrome, is often at the core of many chronic diseases

Freezing damage: If you know or suspect the pen was frozen, discard it even if it appears normal after thawing

reduced active drug delivery obscures true individual responsiveness

Retatrutide continues to be evaluated in clinical research and is not currently available as a routine prescription medication

First, you need to understand all your options so you can compare them properly

GLP-1 receptor agonists have a low risk of hypoglycaemia when used alone